Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
RSC Medicinal Chemistry|December 23, 2022
The future of chemical probes is diversitySusanne Müller, Stephen Frye, Jonathan BaellACS Omega|September 9, 2024
Novel Diacyl-hydrazide Compounds as Potential Therapeutics for Visceral LeishmaniasisBernhard Jandl, Rebecca Zheng, Markus Muttenthaler, et al.The Journal of Organic Chemistry|April 14, 2015
Regio- and stereoselective iodoacyloxylations of alkynesDaniel L Priebbenow, Robert W Gable, Jonathan BaellFuture Medicinal Chemistry|May 9, 2013
Ask the experts: past, present and future of the rule of fiveJonathan Baell, Miles Congreve, Paul Leeson, et al.Biochimica Et Biophysica Acta. Molecular Cell Research|May 20, 2023
Kinases in cerebral cavernous malformations: Pathogenesis and therapeutic targetsChunxiao Qi, Richard Sean Bujaroski, Jonathan Baell, et al.RSC Medicinal Chemistry|January 22, 2021
Hit-to-lead optimization of novel benzimidazole phenylacetamides as broad spectrum trypanosomacidesNicole McNamara, Raphael Rahmani, Melissa L Sykes, et al.Microbial Drug Resistance (Larchmont, N.Y.)|June 25, 2003
Inhibition studies of sulfonamide-containing folate analogs in yeastOnisha Patel, Jacqueline Satchell, Jonathan Baell, et al.Combinatorial Chemistry & High Throughput Screening|January 14, 2014
A perspective on 10-years HTS experience at the Walter and Eliza Hall Institute of Medical Research - eighteen million assays and countingKurt Lackovic, Guillaume Lessene, Hendrik Falk, et al.Cancer Letters|March 17, 2006
Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors)Yumiko Hirokawa, Alexander Levitzki, Guillaume Lessene, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Facile Synthesis and Preliminary Structure-Activity Analysis of New Sulfonamides Against Trypanosoma bruceiAdel A Rashad, Amy J Jones, Vicky M Avery, et al.Pageof 5